Advertisement
Screener

Akari Therapeutics, Plc (AKTX) Auditor

Akari Therapeutics, Plc Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-30: Fiscal year end 2025-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location New York, New York.
  • 2025-04-15: Fiscal year end 2024-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location New York, New York.
  • 2024-03-29: Fiscal year end 2023-12-31; Auditor BDO USA, P.C.; PCAOB firm ID 243; Location New York, New York.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-302025-12-31BDO USA, P.C.243New York, New YorkNo
2025-04-152024-12-31BDO USA, P.C.243New York, New YorkNo
2024-03-292023-12-31BDO USA, P.C.243New York, New YorkNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
ELI LILLY & Co (LLY)United States$1,113.804B42.28
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94